Page 1837 - Williams Hematology ( PDFDrive )

1812 Part XI: Malignant Lymphoid Diseases <CN>: <CT> PB

64. Preud’homme JL, Bauwens M, Dumont G, et al: Cast nephropathy in mu heavy chain 82. Sala P, Tonutti E, Pizzolitto S, et al: Immunochemical and structural characterization of
disease. Clin Nephrol 48:118, 1997. an IgG1 heavy chain disease. Ric Clin Lab 19:59, 1989.
65. Maeda A, Mori M, Torii S, et al: Multiple extranodal tumors in mu-heavy chain disease. 83. Franklin EC, Frangione B: The molecular defect in a protein (CRA) found in gamma-1
Int J Hematol 84:286, 2006. heavy chain disease, and its genetic implications. Proc Natl Acad Sci U S A 68:187, 1971.
66. Alexander A, Anicito I, Buxbaum J: Gamma heavy chain disease in man: Genomic 84. Nabeshima Y, Ikenaka T: N- and C-terminal amino acid sequences of a gamma-heavy
sequence reveals two noncontiguous deletions in a single gene. J Clin Invest 82:1244, chain disease protein YOK. Immunochemistry 13:245, 1976.
1988. 85. Guglielmi P, Bakhshi A, Cogne M, et al: Multiple genomic defects result in an alterna-
67. Frangione B, Rosenwasser E, Prelli F, Franklin EC: Primary structure of human gamma tive RNA splice creating a human gamma H chain disease protein. J Immunol 141:1762,
3 immunoglobulin deletion mutant: Gamma 3 heavy-chain disease protein Wis. Bio- 1988.
chemistry 19:4304, 1980. 86. Biewenga J, Frangione B, Franklin EC, van Loghem E: A gamma l heavy-chain disease
68. Frangione B: A new immunoglobulin variant: Gamma3 heavy chain disease protein protein (EST) lacking the entire VH and CH1 domains. Scand J Immunol 11:601, 1980.
CHI. Proc Natl Acad Sci U S A 73:1552, 1976. 87. Bentaboulet M, Mihaesco E, Gendron MC, et al: Genomic alterations in a case of alpha
69. Frangione B, Franklin EC: Correlation between fragmented immunoglobulin genes heavy chain disease leading to the generation of composite exons from the JH region.
and heavy chain deletion mutants. Nature 281:600, 1979. Eur J Immunol 19:2093, 1989.
70. Wolfenstein-Todel C, Frangione B, Prelli F, Franklin EC: The amino acid sequence of 88. Tsapis A, Bentaboulet M, Pellet P, et al: The productive gene for alpha-H chain disease
“heavy chain disease” protein ZUC: Structure of the Fc fragment of immunoglobulin protein MAL is highly modified by insertion-deletion processes. J Immunol 143:3821,
G3. Biochem Biophys Res Commun 71:907, 1976. 1989.
71. Arnaud P, Wang AC, Gianazza E, et al: Gamma heavy chain disease protein CHA: 89. Wolfenstein-Todel C, Mihaesco E, Frangione B: “Alpha chain disease” protein def:
Immunological and structural studies. Mol Immunol 18:379, 1981. Internal deletion of a human immunoglobulin A1 heavy chain. Proc Natl Acad Sci U S
72. Prelli F, Frangione B: Franklin’s disease: Ig gamma 2 H chain mutant BUR. J Immunol A 71:974, 1974.
148:949, 1992. 90. Wolfenstein-Todel C, Mihaesco E, Frangione B: Variant of a human immunoglobulin:
73. Cooper SM, Franklin EC, Frangione B: Molecular defect in a gamma-2 heavy chain. “alpha chain disease” protein AIT. Biochem Biophys Res Commun 65:47, 1975.
Science 176:187, 1972. 91. Cogne M, Preud’homme JL: Gene deletions force nonsecretory alpha-chain disease
74. Frangione B, Franklin EC, Smithies O: Unusual genes at the aminoterminus of human plasma cells to produce membrane-form alpha-chain only. J Immunol 145:2455,
immunoglobulin variants. Nature 273:400, 1978. 1990.
75. Terry WD, Ohms J: Implications of heavy chain disease protein sequences for multiple 92. Fakhfakh F, Dellagi K, Ayadi H, et al: Alpha heavy chain disease alpha mRNA contain
gene theories of immunoglobulin synthesis. Proc Natl Acad Sci U S A 66:558, 1970. nucleotide sequences of unknown origins. Eur J Immunol 22:3037, 1992.
76. Smith LL, Barton BP, Garver FA, et al: Physicochemical and immunochemical proper- 93. Barnikol-Watanabe S, Mihaesco E, Mihaesco C, et al: The primary structure of
ties of gamma l heavy chain disease protein BAZ. Immunochemistry 15:323, 1978. mu-chain-disease protein BOT: Peculiar amino-acid sequence of the N-terminal
77. Rabin BS, Moon J: Clinical findings in a case of newly defined gamma heavy chain 42 positions. Hoppe Seylers Z Physiol Chem 365:105, 1984.
disease protein. Clin Exp Immunol 14:563, 1973. 94. Mihaesco C, Ferrara P, Guillemot JC, et al: A new extra sequence at the amino terminal
78. Franklin EC, Prelli F, Frangione B: Human heavy chain disease protein WIS: Implica- of a mu heavy chain disease protein (DAG). Mol Immunol 27:771, 1990.
tions for the organization of immunoglobulin genes. Proc Natl Acad Sci U S A 76:452, 95. Franklin EC, Frangione B, Prelli F: The defect in mu heavy chain disease protein GLI. J
1979. Immunol 116:1194, 1976.
79. Frangione B, Lee L, Haber E, Bloch KJ: Protein Hal: Partial deletion of a “γ” immuno- 96. Bakhshi A, Guglielmi P, Siebenlist U, et al: A DNA insertion/deletion necessitates an
globulin gene(s) and apparent reinitiation at an internal AUG codon. Proc Natl Acad Sci aberrant RNA splice accounting for a mu heavy chain disease protein. Proc Natl Acad
U S A 70:1073, 1973. Sci U S A 83:2689, 1986.
80. Franklin EC, Kyle R, Seligmann M, Frangione B: Correlation of protein structure and 97. Cogne M, Aucouturier P, Brizard A, et al: Complete variable region deletion in a mu
immunoglobulin gene organization in the light of two new deleted heavy chain disease heavy chain disease protein (ROUL): Correlation with light chain secretion. Leuk Res
proteins. Mol Immunol 16:919, 1979. 17:527, 1993.
81. Hauke G, Schiltz E, Bross KJ, et al: Unusual sequence of immunoglobulin L-chain rear- 98. Lebreton JP, Ropartz C, Rousseaus J, et al: Immunochemical and biochemical study of
rangements in a gamma heavy chain disease patient. Scand J Immunol 36:463, 1992. a human Fcmu-like fragment (mu-chain disease). Eur J Immunol 5:179, 1975.

Kaushansky_chapter 110_p1803-1812.indd 1812 9/18/15 10:00 AM